These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23079660)

  • 1. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.
    Zhang X; Zhao X; Fiskus W; Lin J; Lwin T; Rao R; Zhang Y; Chan JC; Fu K; Marquez VE; Chen-Kiang S; Moscinski LC; Seto E; Dalton WS; Wright KL; Sotomayor E; Bhalla K; Tao J
    Cancer Cell; 2012 Oct; 22(4):506-523. PubMed ID: 23079660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.
    Zhao X; Lwin T; Zhang X; Huang A; Wang J; Marquez VE; Chen-Kiang S; Dalton WS; Sotomayor E; Tao J
    Leukemia; 2013 Dec; 27(12):2341-50. PubMed ID: 23538750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma.
    Wang L; Zhang X; Jia LT; Hu SJ; Zhao J; Yang JD; Wen WH; Wang Z; Wang T; Zhao J; Wang RA; Meng YL; Nie YZ; Dou KF; Chen SY; Yao LB; Fan DM; Zhang R; Yang AG
    Hepatology; 2014 May; 59(5):1850-63. PubMed ID: 24002871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
    Zhang X; Chen X; Lin J; Lwin T; Wright G; Moscinski LC; Dalton WS; Seto E; Wright K; Sotomayor E; Tao J
    Oncogene; 2012 Jun; 31(24):3002-3008. PubMed ID: 22002311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
    Sander S; Bullinger L; Klapproth K; Fiedler K; Kestler HA; Barth TF; Möller P; Stilgenbauer S; Pollack JR; Wirth T
    Blood; 2008 Nov; 112(10):4202-12. PubMed ID: 18713946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.
    Karkhanis V; Alinari L; Ozer HG; Chung J; Zhang X; Sif S; Baiocchi RA
    J Biol Chem; 2020 Jan; 295(5):1165-1180. PubMed ID: 31822509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression.
    Kuser-Abali G; Alptekin A; Cinar B
    Epigenetics; 2014 Apr; 9(4):634-43. PubMed ID: 24499724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
    Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
    Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas.
    Tian X; Pelton A; Shahsafaei A; Dorfman DM
    Mod Pathol; 2016 Sep; 29(9):1050-7. PubMed ID: 27282353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
    Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
    Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.
    Zhang X; Zhang X; Wang T; Wang L; Tan Z; Wei W; Yan B; Zhao J; Wu K; Yang A; Zhang R; Jia L
    Cancer Lett; 2018 Jul; 426():98-108. PubMed ID: 29653269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
    Zhang Q; Padi SK; Tindall DJ; Guo B
    Cell Death Dis; 2014 Oct; 5(10):e1486. PubMed ID: 25341040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
    Koh CM; Iwata T; Zheng Q; Bethel C; Yegnasubramanian S; De Marzo AM
    Oncotarget; 2011 Sep; 2(9):669-83. PubMed ID: 21941025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.
    Lu J; He ML; Wang L; Chen Y; Liu X; Dong Q; Chen YC; Peng Y; Yao KT; Kung HF; Li XP
    Cancer Res; 2011 Jan; 71(1):225-33. PubMed ID: 21199804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-26a Mediates Ultraviolet B-Induced Apoptosis by Targeting Histone Methyltransferase EZH2 Depending on Myc Expression.
    Zhang T; Qian H; Hu C; Lu H; Li JB; Wu YF; Li W
    Cell Physiol Biochem; 2017; 43(3):1188-1197. PubMed ID: 28977801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of enhancer of zests homolog 2 in lymphoma.
    Guo SQ; Zhang YZ
    Chin Med J (Engl); 2012 Oct; 125(20):3735-9. PubMed ID: 23075734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases.
    Shi M; Shahsafaei A; Liu C; Yu H; Dorfman DM
    Leuk Lymphoma; 2015 Jul; 56(7):2087-91. PubMed ID: 25263318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.
    Kanduri M; Sander B; Ntoufa S; Papakonstantinou N; Sutton LA; Stamatopoulos K; Kanduri C; Rosenquist R
    Epigenetics; 2013 Dec; 8(12):1280-8. PubMed ID: 24107828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.
    Kaur M; Cole MD
    Cancer Res; 2013 Jan; 73(2):695-705. PubMed ID: 23135913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.